Nicolas Noulin

2.1k total citations
20 papers, 1.2k citations indexed

About

Nicolas Noulin is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Immunology. According to data from OpenAlex, Nicolas Noulin has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Nicolas Noulin's work include Respiratory viral infections research (8 papers), Immune Response and Inflammation (7 papers) and Neonatal Respiratory Health Research (6 papers). Nicolas Noulin is often cited by papers focused on Respiratory viral infections research (8 papers), Immune Response and Inflammation (7 papers) and Neonatal Respiratory Health Research (6 papers). Nicolas Noulin collaborates with scholars based in France, United States and United Kingdom. Nicolas Noulin's co-authors include Bernhard Ryffel, Isabelle Couillin, Bruno Schnyder, Valérie Quesniaux, Silvia Schnyder‐Candrian, Isabelle Guénon, Vincent Lagente, Paméla Gasse, Shizuo Akira and Sabine Charron and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Nicolas Noulin

19 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Noulin France	11	489	482	349	215	187	20	1.2k
Tine Demoor Belgium	14	310 0.6×	515 1.1×	455 1.3×	204 0.9×	285 1.5×	16	1.3k
Carla M. T. Bauer Canada	20	438 0.9×	585 1.2×	398 1.1×	241 1.1×	329 1.8×	28	1.4k
Yoshiki Shiraishi Japan	21	423 0.9×	528 1.1×	234 0.7×	209 1.0×	450 2.4×	57	1.4k
Hiroaki Mitsuzawa Japan	22	740 1.5×	605 1.3×	277 0.8×	277 1.3×	83 0.4×	36	1.5k
Fernando Botelho Canada	22	525 1.1×	316 0.7×	298 0.9×	177 0.8×	293 1.6×	34	1.3k
Koji Kuronuma Japan	21	301 0.6×	953 2.0×	290 0.8×	362 1.7×	277 1.5×	83	1.7k
Jemma Mayall Australia	9	476 1.0×	265 0.5×	307 0.9×	95 0.4×	386 2.1×	17	1.0k
Naoki Shimojo Japan	26	447 0.9×	222 0.5×	491 1.4×	286 1.3×	478 2.6×	127	2.0k
J M Cavaillon France	14	693 1.4×	292 0.6×	297 0.9×	228 1.1×	113 0.6×	37	1.4k
Susan B. Morris United States	20	571 1.2×	504 1.0×	197 0.6×	604 2.8×	127 0.7×	30	1.3k

Countries citing papers authored by Nicolas Noulin

Since Specialization

Citations

This map shows the geographic impact of Nicolas Noulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Noulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Noulin more than expected).

Fields of papers citing papers by Nicolas Noulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Noulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Noulin. The network helps show where Nicolas Noulin may publish in the future.

Co-authorship network of co-authors of Nicolas Noulin

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Noulin. A scholar is included among the top collaborators of Nicolas Noulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Noulin. Nicolas Noulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cass, Lindsey, et al.. (2025). A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge. Infectious Diseases and Therapy. 14(8). 1697–1714.

Oxford, John, Anthony Catchpole, Anita Mann, et al.. (2022). A Brief History of Human Challenge Studies (1900–2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D’etre, Ethnography, Selection of Volunteers and Unit Design. Current topics in microbiology and immunology. 445. 1–32. 1 indexed citations

Smith, John A., Michael M. Kitt, Alan Bell, et al.. (2022). Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial. Pulmonary Therapy. 8(3). 297–310. 5 indexed citations

Sadoff, Jerald, Els De Paepe, John P. DeVincenzo, et al.. (2021). Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study. The Journal of Infectious Diseases. 226(3). 396–406. 67 indexed citations

Coakley, Eoin, Alaa Ahmad, Kajal Larson, et al.. (2019). LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study. Open Forum Infectious Diseases. 6(Supplement_2). S995–S995. 7 indexed citations

DeVincenzo, John P., Els De Paepe, Arangassery Rosemary Bastian, et al.. (2019). 902. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of a Single Immunization of Ad26.RSV.preF against RSV Infection in a Viral Challenge Model in Healthy Adults. Open Forum Infectious Diseases. 6(Supplement_2). S27–S28. 8 indexed citations

Lambkin‐Williams, Rob, Nicolas Noulin, Alex Mann, Andrew Catchpole, & Anthony Gilbert. (2018). The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. Respiratory Research. 19(1). 123–123. 43 indexed citations

Catchpole, Andrew, et al.. (2018). The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process. BMC Research Notes. 11(1). 620–620. 6 indexed citations

Noulin, Nicolas, Andrew Catchpole, Hosnieh Fathi, et al.. (2016). Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE. 11(1). e0145902–e0145902. 9 indexed citations

10.

Laxton, Carl, Andrew Catchpole, E. Donnall Thomas, et al.. (2015). Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM). Journal of Virological Methods. 224. 83–90. 6 indexed citations

11.

Mann, Alex, Nicolas Noulin, Andrew Catchpole, et al.. (2014). Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge. PLoS ONE. 9(5). e93761–e93761. 27 indexed citations

12.

Sécher, Thomas, Fernando Rodrigues Coelho, Nicolas Noulin, et al.. (2012). Enhancement of Methacholine-Evoked Tracheal Contraction Induced by Bacterial Lipopolysaccharides Depends on Epithelium and Tumor Necrosis Factor. PubMed. 2012. 1–10. 53 indexed citations

13.

Janot, Laure, Jean‐Claude Sirard, Thomas Sécher, et al.. (2009). Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. European Journal of Immunology. 39(6). 1587–1596. 42 indexed citations

14.

Doz, Emilie, Nicolas Noulin, Elisabeth Boichot, et al.. (2008). Cigarette Smoke-Induced Pulmonary Inflammation Is TLR4/MyD88 and IL-1R1/MyD88 Signaling Dependent. The Journal of Immunology. 180(2). 1169–1178. 269 indexed citations

15.

Togbe, Dieudonnée, Sergei I. Grivennikov, Nicolas Noulin, et al.. (2007). T cell‐derived TNF down‐regulates acute airway response to endotoxin. European Journal of Immunology. 37(3). 768–779. 10 indexed citations

16.

Togbe, Dieudonnée, Silvia Schnyder‐Candrian, Bruno Schnyder, et al.. (2007). Toll‐like receptor and tumour necrosis factor dependent endotoxin‐induced acute lung injury. International Journal of Experimental Pathology. 88(6). 387–391. 111 indexed citations

17.

Gasse, Paméla, Caroline Mary, Isabelle Guénon, et al.. (2007). IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. Journal of Clinical Investigation. 117(12). 3786–99. 380 indexed citations

18.

Togbe, Dieudonnée, Nicolas Noulin, Valérie Quesniaux, et al.. (2006). Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways. Laboratory Investigation. 86(11). 1126–1135. 22 indexed citations

19.

Schnyder‐Candrian, Silvia, Valérie Quesniaux, Franco Di Padova, et al.. (2005). Dual Effects of p38 MAPK on TNF-Dependent Bronchoconstriction and TNF-Independent Neutrophil Recruitment in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome. The Journal of Immunology. 175(1). 262–269. 80 indexed citations

20.

Noulin, Nicolas, Valérie Quesniaux, Silvia Schnyder‐Candrian, et al.. (2005). Both Hemopoietic and Resident Cells Are Required for MyD88-Dependent Pulmonary Inflammatory Response to Inhaled Endotoxin. The Journal of Immunology. 175(10). 6861–6869. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact